Lyudmila Bazhenova

University of California

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (5)

Stephen Liu

Associate Professor

Georgetown University School of Medicine

UNITED STATES

View details

Joseph Michael Unger

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Dawn L. Hershman

Columbia University Irving Medical Center

UNITED STATES

View details

Mary Redman

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Amit Kulkarni

University of Minnesota

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lyudmila Bazhenova

Research Interests

Explore related searches

Contact this professor

Articles (11)

Novel Approaches for Dynamic Visualization of Adverse Event Data in Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG)

Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With NTRK Fusion-Positive Solid Tumors

Resistance to EGFR Tyrosine Kinase Inhibitor Therapy in Non–Small-Cell Lung Cancer via Newly Acquired Targetable Oncogenic Driver Alterations With an Emphasis on <i>BRAF</i>: Case Series and Literature Review of Treatment

First-in-Human Phase I/IB Dose-Finding Study of Adagrasib (MRTX849) in Patients With Advanced KRASG12C Solid Tumors (KRYSTAL-1)

Resistance to EGFR Tyrosine Kinase Inhibitor Therapy in Non–Small-Cell Lung Cancer via Newly Acquired Targetable Oncogenic Driver Alterations With an Emphasis on BRAF: Case Series and Literature Review of Treatment

Trastuzumab Deruxtecan in HER2-Mutant Non–Small-Cell Lung Cancer

A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer

Amivantamab compared with real-world therapies in patients with advanced non-small cell lung cancer harboring EGFR exon 20 insertion mutations who progressed after platinum-based chemotherapy

Clinicopathologic and molecular characteristics of EGFR-mutant lung adenocarcinomas that transform to small cell lung cancer after TKI therapy

Erratum: Correction: Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients with NTRK Fusion-Positive Solid Tumors (Clinical cancer research : an official journal of the American Association for Cancer Research (2022) 28 7 (1302-1312))

Update on Lorlatinib: Role in Reducing the Risk of Disease Progression in ALK-Positive NSCLC

Collaborators (5)

Stephen Liu

Joseph Michael Unger

Dawn L. Hershman

Mary Redman

Amit Kulkarni

Make your next move.